OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents
Kushagra Kashyap, Mohammad Imran Siddiqi
Molecular Diversity (2021) Vol. 25, Iss. 3, pp. 1517-1539
Closed Access | Times Cited: 14

Showing 14 citing articles:

Drug repositioning for Parkinson’s disease: an emphasis on artificial intelligence approaches
Iman Karimi-Sani, Mehrdad Sharifi, Nahid Abolpour, et al.
Ageing Research Reviews (2025) Vol. 104, pp. 102651-102651
Closed Access | Times Cited: 1

Development of Novel Anti-Leishmanials: The Case for Structure-Based Approaches
Mohini Soni, J. Venkatesh Pratap
Pathogens (2022) Vol. 11, Iss. 8, pp. 950-950
Open Access | Times Cited: 21

A Survey on Computational Methods in Drug Discovery for Neurodegenerative Diseases
Caterina Vicidomini, Francesco Fontanella, Tiziana D’Alessandro, et al.
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1330-1330
Open Access | Times Cited: 4

Role of Neuroglobin in the Neuroprotective Actions of Estradiol and Estrogenic Compounds
George E. Barreto, Andrew J. McGovern, Luis Miguel García‐Segura
Cells (2021) Vol. 10, Iss. 8, pp. 1907-1907
Open Access | Times Cited: 20

Quality of Service Generalization using Parallel Turing Integration Paradigm to Support Machine Learning
Abdul Razaque, Mohamed Ben Haj Frej, Gulnara Bektemyssova, et al.
Electronics (2023) Vol. 12, Iss. 5, pp. 1129-1129
Open Access | Times Cited: 5

Identifying novel and potent inhibitors of EGFR protein for the drug development against the breast cancer
Arif Jamal Siddiqui, Sadaf Jahan, Mitesh Patel, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 23, pp. 14460-14472
Closed Access | Times Cited: 4

The role of glutamic acid-modified silica nanoparticles in promoting brain health
Essia Hamdi, Slah Hidouri, Ana‐Belén Muñiz‐González, et al.
Advances in Redox Research (2024) Vol. 10, pp. 100095-100095
Open Access | Times Cited: 1

Identification of Potential Aldose Reductase Inhibitors Using Convolutional Neural Network-Based in Silico Screening
Kushagra Kashyap, Pinaki Prasad Mahapatra, Shakil Ahmed, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 20, pp. 6261-6282
Closed Access | Times Cited: 3

Editorial: Model-informed drug development and evidence-based translational pharmacology
Jinxin Zhao, Xiao Zhu, Songwen Tan, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 3

Advances in Developing Small Molecule Drugs for Alzheimer's Disease
Wei Zhang, Liujie Zhang, Mingti Lv, et al.
Current Alzheimer Research (2024) Vol. 21, Iss. 4, pp. 221-231
Closed Access

Deep convolutional neural network-based identification and biological evaluation of MAO-B inhibitors
Kushagra Kashyap, Girdhar Bhati, Shakil Ahmed, et al.
International Journal of Biological Macromolecules (2024) Vol. 281, pp. 136438-136438
Closed Access

Benzyl-para-di-[5-methyl-4-(n-octylamino) pyrimidin-2(1H)one] as an interferon beta (IFN-β) modulator
Lena Trifonov, Mariya Yurchenko, Astrid Skjesol, et al.
Molecular Diversity (2021) Vol. 26, Iss. 4, pp. 2175-2188
Closed Access | Times Cited: 3

Page 1

Scroll to top